Detalhe da pesquisa
1.
CD39 in the development and progression of pulmonary arterial hypertension.
Purinergic Signal
; 18(4): 409-419, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947229
2.
Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19.
Stroke
; 52(5): 1895-1904, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794655
3.
Active Micropump-Mixer for Rapid Antiplatelet Drug Screening in Whole Blood.
Anal Chem
; 91(16): 10830-10839, 2019 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31343155
4.
Targeting CD39 Toward Activated Platelets Reduces Systemic Inflammation and Improves Survival in Sepsis: A Preclinical Pilot Study.
Crit Care Med
; 47(5): e420-e427, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30730441
5.
A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury.
Eur Heart J
; 39(2): 111-116, 2018 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28472483
6.
CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages.
J Autoimmun
; 88: 131-138, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29103803
7.
Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.
Purinergic Signal
; 13(2): 259-265, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28343356
8.
Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?
Blood
; 121(16): 3067-75, 2013 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23380744
9.
Development of endothelial-targeted CD39 as a therapy for ischemic stroke.
J Thromb Haemost
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754782
10.
The myotubularin phosphatase MTMR4 regulates sorting from early endosomes.
J Cell Sci
; 123(Pt 18): 3071-83, 2010 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20736309
11.
The potential role of protease systems in hemophilic arthropathy.
Blood Adv
; 6(18): 5505-5515, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580335
12.
The Need for Individualized Risk Assessment in Cardiovascular Disease.
J Pers Med
; 12(7)2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887637
13.
Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease.
J Pers Med
; 12(9)2022 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36143280
14.
Role of Purinergic Signalling in Endothelial Dysfunction and Thrombo-Inflammation in Ischaemic Stroke and Cerebral Small Vessel Disease.
Biomolecules
; 11(7)2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34356618
15.
Early Endothelial Activation in a Mouse Model of Graft vs Host Disease Following Chemotherapy.
Front Immunol
; 12: 708554, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34421913
16.
Characterization of a novel model of global forebrain ischaemia-reperfusion injury in mice and comparison with focal ischaemic and haemorrhagic stroke.
Sci Rep
; 10(1): 18170, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097782
17.
Phosphatidylinositol 3-phosphate [PtdIns3P] is generated at the plasma membrane by an inositol polyphosphate 5-phosphatase: endogenous PtdIns3P can promote GLUT4 translocation to the plasma membrane.
Mol Cell Biol
; 26(16): 6065-81, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16880518
18.
The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation.
Mol Biol Cell
; 17(2): 607-22, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16280363
19.
Glycosylation changes in hFUT1 transgenic mice increase TCR signaling and apoptosis resulting in thymocyte maturation arrest.
Mol Immunol
; 45(8): 2401-10, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18155296
20.
The PI 3-kinase PI3KC2α regulates mouse platelet membrane structure and function independently of membrane lipid composition.
FEBS Lett
; 593(1): 88-96, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30421419